Relation between the angiotensinogen (AGT) M235T gene polymorphism and blood pressure in a large, homogeneous study population

Size: px
Start display at page:

Download "Relation between the angiotensinogen (AGT) M235T gene polymorphism and blood pressure in a large, homogeneous study population"

Transcription

1 (2003) 17, & 2003 Nature Publishing Group All rights reserved /03 $ ORIGINAL ARTICLE Relation between the angiotensinogen (AGT) M235T gene polymorphism and blood pressure in a large, homogeneous study population JR Ortlepp 1, J Metrikat 2, V Mevissen 1, F Schmitz 1, M Albrecht 2, P Maya-Pelzer 2, P Hanrath 1, K Zerres 3 and R Hoffmann 1 1 Medical Clinic I, University Hospital of Aachen, Pauwelsstrasse 30, Aachen, Germany; 2 German Air Force Institute of Aviation Medicine, Furstenfeldbruck, Germany; 3 Institute of Human Genetics, University Hospital of Aachen, Pauwelsstrasse 30, Aachen, Germany The aim of this study was to assess the association of the angiotensinogen M235T polymorphism with arterial blood pressure (BP) at rest and under physical stress in a homogeneous large-scale study population. In all, 1903 men who passed routine medical examination for military flying duty were recruited. BP and heart rate were measured at rest, during, and after bicycle ergometry. Genotyping for the AGT M235T polymorphism was carried out by PCR and RFLP technique. The AGT T235 allele was associated with a significantly higher diastolic BP (n ¼ 1903; MM , MT , TT ; P ¼ 0.003). Pulse pressure (PP) at rest differed significantly between AGT genotypes (n ¼ 1903; MM mmhg, MT mmhg, TT mmhg; P ¼ 0.001). During physical activity, BP values showed no significant difference between genotypes. In healthy young men, the AGT T235 allele is significantly associated with elevated diastolic BP but also reduced PP at rest. During physical activity, the AGT polymorphism had no impact on blood pressure, indicating the existence of other counteracting mechanisms, which might balance the influence of this gene. (2003) 17, doi: /sj.jhh Keywords: angiotensinogen; AGT; polymorphism; blood pressure; genetics Introduction The regulation of arterial blood pressure (BP) is complex and under the control of different physiological systems. The renin angiotensin aldosterone system (RAAS) is one of the important regulatory systems. Genes encoding products of the RAAS are plausible candidate genes for modifying blood pressure. The angiotensinogen gene (AGT) is one of the few candidates that has been investigated extensively and its genetic variant in exon 2 shows a transition resulting in replacement of methionine by threonine at amino-acid position 235 (M235T). Positive associations between the AGT M235T polymorphism, plasma angiotensinogen levels, and essential arterial hypertension indicate a pathway by which the AGT gene determines arterial BP. 1 5 Correspondence: Dr JR Ortlepp, Medical Clinic I, University Hospital of Aachen, Pauwelsstrasse 30, Aachen 52057, Germany. jrortlepp@ukaachen.de Received 6 February 2003; revised 23 April 2003; accepted 25 April 2003 However, studies in African and Asian populations could not equally support these findings, 6 9 indicating the importance of other genetic factors interfering with the AGT gene. Moreover, the allele frequency of the AGT M235T polymorphism varies strongly within the different ethnic groups. One study found a significant increase in T235 allele frequency in patients with hypertension that was restricted to men, 10 thus gender might also influence the effect of the AGT gene. The diagnosis of essential arterial hypertension is based on BP above a defined cutoff value. However, a recent study indicated that individuals with BP values that have been considered to be at the upper limit of normality already have an increased risk of cardiovascular disease. 11 Thus, arterial hypertension should not be considered as a dichotomous diagnosis of having a BP below or above a certain threshold. Similarly, the same seems to be true for genetic determination of arterial hypertension. Many genes might influence the arterial BP without generating an arterial hypertension. It is the concurrence of multiple factors (gene polymorphisms, gender, age, environ-

2 556 mental conditions), which leads to the manifestation of arterial hypertension. Thus, to study the effect of one gene polymorphism, it might be appropriate to analyse quantitative traits in a homogeneous (homogeneous for: gender, race, occupation, social status, physical fitness, and age) population, rather than categorical traits (like healthy vs arterial hypertension) in heterogeneous populations. The aim of this study was to assess the association of the AGT M235T polymorphism with arterial BP in a large-scale study population of completely healthy young men. Materials and methods Study population The subjects were German male aviators who passed routine medical examination for military flying duties. Physical activity was assessed by standardized questionnaires. Participants were included into the study during routine medical qualification for flying duty. A total of 2000 men were screened and 1903 gave written informed consent (95%) and formed the study population. The study was approved by the local ethical committees. Body mass index Body weight and height were measured between 7 a.m. and 8 a.m. before breakfast, after urination, and undressed, to calculate BMI by division of weight by square of height (kg/m 2 ). Blood pressure and heart rate measurement at rest BP and heart rate (HR) were measured manually by trained personnel after 5 min of rest in supine position in a quiet room between 7 a.m. and 9 a.m. at neutral, ambient temperature. Systolic (SBP), diastolic (DBP), and mean blood pressure (MBP) as well as pulse pressure (PP ¼ SBP DBP) were assessed. DBP was taken as Korotkov V. BP and HR during and after physical exercise, physical fitness (PWC 170) Ergometry was performed in 1750 men. Physical fitness (determined by physical working capacity at an HR of 170 bpm ¼ PWC 170) was assessed by standard cycle ergometry in 451 sitting position and expressed as the achieved performance (watts (W)) per kilogram of body weight (kg) at an actual HR of 170 bpm. Ergometric power was increased every 3 min by steps of 50 W, starting from 100 W up to the point of physical exhaustion or commonly accepted termination criteria. Ergometric performance was monitored by continuous ECG, supervised by an experienced physician. HR, SBP, DBP, MBP, and PP were assessed 3 min, and 6 min during ergometry and 3 min after ergometry. At 3 min ergometry corresponds to 3 min 100 W, 6 min ergometry corresponds to 3 min 100 W plus 3 min 150 W. Genotyping Genomic DNA of patients was extracted from whole blood using the InVitek Blood Kit (InVitek, Berlin, Germany). The AGT M235T polymorphism was tested as described previously. 1 Statistical analysis Continuous data are presented as mean 7 s.d. and categorical data are presented as frequencies. Differences in BP were calculated by ANOVA. A linear regression analysis was performed to evaluate the impact of AGT on pulse pressure. A multivariable analysis was performed including BMI, age, and AGT genotype. Significant differences were defined Table 1 Characteristics of the study population N 1903 Age (year) Height (cm) Weight (cm) BMI (kg/m 2 ) SBP at rest (mmhg) DBP at rest (mmhg) MBP at rest (mmhg) PP at rest (mmhg) HR at rest (bpm) Physical activity (h/week) Physical fitness PWC170 (W/kg) SBP at 3 min ergometry (mmhg) DBP at 3 min ergometry (mmhg) MBP at 3 min ergometry (mmhg) PP at 3 min ergometry (mmhg) HR at 3 min ergometry (bpm) SBP at 6 min ergometry (mmhg) DBP at 6 min ergometry (mmhg) MBP at 6 min ergometry (mmhg) PP at 6 min ergometry (mmhg) HR at 6 min ergometry (bpm) SBP 3 min after ergometry (mmhg) DBP 3 min after ergometry (mmhg) MBP 3 min after ergometry (mmhg) PP 3 min after ergometry (mmhg) HR 3 min after ergometry (bpm) Physical fitness (determined by physical working capacity at an HR of 170 bpm=pwc170) was assessed by standard cycle ergometry in 451 sitting position and expressed as the achieved performance (watt (W) per kilogram of body weight (kg) at an actual HR of 170 bpm). Ergometric power was increased every 3 min by steps of 50 W, starting from 100 W up to the point of physical exhaustion or commonly accepted termination criteria. A 3 min ergometry corresponds to 3 min of 100 W, 6 min ergometry corresponds to 3 min of 100 W plus 3 min of 150 W; ergometry was performed in 1750 men. SBP=systolic blood pressure; DBP=diastolic blood pressure, MBP=mean blood pressure; PP=pulse pressure, HR=heart rate, PWC 170=physical working capacity at a heart rate of 170 bpm.

3 as a two-sided P-valueo0.05. Statistical figures show mean values with 95% confidence interval. All calculations were performed with SPSS for Windows s The null hypothesis was that men with different AGT genotypes do not have different BP values. Results Phenotypes The characteristics of the study population are given in Table 1. The study population represents a hyperhealthy population with few obese men and high physical activity and fitness. Genotypes The frequencies of the AGT M235T genotypes and alleles are shown in Table 2. Table 2 Genotype and allele frequencies of the angiotensinogen AGT M235T polymorphism AGT 235 genotype MM (n(%)) 627 (32.9%) TM (n(%)) 1039 (54.6%) TT (n(%)) 237 (12.5%) AGT 235 allele frequency M T Relation of AGT genotype and BP values As given in Table 3, the AGT genotypes were associated with different DBP and PP at rest. Men homozygous for the T allele had the lowest PP at rest. These findings are further illustrated in Figure 1. During and after physical activity BP values did not differ between the AGT genotypes (Table 3). Multivariable analysis In a multivariable analysis for DBP and PP including age, BMI, and AGT genotype, all variables were significantly associated with DBP (age: F ¼ , Po0.001; BMI: F ¼ 9.535, P ¼ 0.002; AGT genotype: F ¼ 5.390, P ¼ 0.005) and PP (age: F ¼ , Po0.001; BMI: F ¼ , Po0.001; AGT genotype: F ¼ 8.012, Po0.001). Discussion The impact of the angiotensinogen gene (AGT) M235T polymorphism on plasma angiotensinogen levels and essential arterial hypertension has been reported. 1 5 However, the finding of an association could not be repeated in all subsequent studies. 6 9 A recent study found a significant impact of the AGT genotype on arterial blood pressure during exercise in 190 men, participating in the HERITAGE family study. 12 However, the impact of the AGT M235T polymorphism on the regulation of arterial blood 557 SBP mean with 95 %CI [mmhg] MBP mean with 95 %CI [mmhg] P=0.486 P=0.323 DBP mean with 95 %CI [mmhg] PP mean with 95 %CI [mmhg] P=0.003 P=0.001 Figure 1 Relation of the AGT M235T genotype with SBP, DBP, MBP, and PP at rest in a study population of 1903 young male active aviators of the German Armed Forces. SBP ¼ systolic blood pressure; DBP ¼ diastolic blood pressure, MBP ¼ mean blood pressure; PP ¼ pulse pressure.

4 558 Table 3 Relation of AGT genotype anthropomorphic parameters and blood pressure values at rest, during, and after exercise AGT 235 MM TM TT P N Age (year) BMI (kg/m 2 ) SBP at rest (mmhg) DBP at rest (mmhg) MBP at rest (mmhg) PP at rest (mmhg) HR at rest (bpm) Physical activity (h/week) Physical fitness PWC170 (W/kg) SBP at 3 min ergometry (mmhg) DBP at 3 min ergometry (mmhg) MBP at 3 min ergometry (mmhg) PP at 3 min ergometry (mmhg) HR at 3 min ergometry (bpm) SBP at 6 min ergometry (mmhg) DBP at 6 min ergometry (mmhg) MBP at 6 min ergometry (mmhg) PP at 6 min ergometry (mmhg) HR at 6 min ergometry (bpm) SBP 3 min after ergometry (mmhg) DBP 3 min after ergometry (mmhg) MBP 3 min after ergometry (mmhg) PP 3 min after ergometry (mmhg) HR 3 min after ergometry (bpm) Physical fitness (determined by physical working capacity at an HR of 170 bpm=pwc170) was assessed by standard cycle ergometry in 451 sitting position and expressed as the achieved performance (watt (W) per kilogram of body weight (kg) at an actual HR of 170 bpm). Ergometric power was increased every 3 min by steps of 50 W, starting from 100 W up to the point of physical exhaustion or commonly accepted termination criteria. A 3 min ergometry corresponds to 3 min of 100 W, 6 min ergometry corresponds to 3 min of 100 W plus 3 min of 150 W; ergometry was performed in 1750 men. SBP=systolic blood pressure; DBP=diastolic blood pressure, MBP=mean blood pressure; PP=pulse pressure, HR=heart rate, PWC 170=physical working capacity at a heart rate of 170 bpm. pressure remains incompletely defined. This study evaluated the relation of the AGT genotype to arterial BP in almost 2000 male active aviators of the German Armed Forces. The major findings of this study are that the AGT M235T gene polymorphism is significantly associated with increased DBP and reduced PP in men at a relatively young age, whereas SBP did not differ significantly between the AGT genotypes. Even when the F-value for the AGT genotype in the multivariable analysis for blood pressure is low, the effect of the AGT genotype on BP regulation is detectable in a period of life far before the general incidence of arterial hypertension. During physical stress, the influence of the AGT gene polymorphism on blood pressure regulation could not be detected. Other additional yet unknown genetic or nongenetic factors could influence this genotype phenotype relation. We speculate that individuals with the T allele might be more prone to cardiovascular diseases later in life, because of the elevation of DBP very early in life. The effect of reduced PP in this young population remains uncertain. Moreover, a difference in the DBP of 2 mmhg might also have only minor relevance. Owing to the relatively small extent of the effect of the AGT genotype polymorphisms of other genes might be associated with BP regulation. In addition, multiple other polymorphisms within the AGT gene have been described and the combination of these multiple AGT polymorphisms might have a higher influence on BP regulation than just a single polymorphism. Further large studies should therefore investigate the haplotype analysis of several candidate genes of the RAAS. The strength of this study is the number of included subjects and the homogeneity of the examined population. In this study population, all subjects had the same gender, race and nationality, similar age, physical fitness, occupation, annual income, social status, and their principal meals were provided by the military five days a week. Thus, this population was controlled for more exogenic factors than it would be possible for patient or population selected study populations. The limitation of this study is that this cohort is not representative of a regular population. For example, we cannot predict the effect of the AGT gene on blood pressure of females, old men, or

5 classical hypertensives. Furthermore, because of the cross-sectional character of this study, we cannot prove that gene carriers with relatively high BP will develop cardiovascular disease years or decades later. However, even if the examined military pilots do not match a regular population, they are in particular suitable to serve as an example for genetic environmental interactions because of their highly homogeneous population characteristics. In summary, we conclude that the effect of the AGT M235T gene polymorphism on blood pressure regulation, even to a small extent, is detectable very early in life, far before the onset of arterial hypertension. Acknowledgement This study was supported by the START program of the University Hospital of Aachen. The work resulting in this report was performed under German Federal Ministry of Defense Contract 21L2-S The opinions expressed in this paper are those of the authors and do not necessarily reflect the opinions or official policy of the German Federal Ministry of Defense. We gratefully acknowledge the support of the medical assistants of Dep. I and the backing of Dep. III of the German Air Force Institute of Aviation Medicine. JR Ortlepp designed the study, did statistical data analysis, J Metrikat coordinated and realized data collection, M Albrecht and P Maya-Pelzer helped with data collection, V Mevissen, F Schmitz, and K Zerres fulfilled genetic analysis, P Hanrath, K Zerres, and R Hoffmann took part in interpretation of data and critical revision. All authors helped to write the report. This work is part of the doctoral thesis of JM Conflict of Interest Statement: None declared. References 1 Jeunemaitre X et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71: Caulfield M et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994; 330: Tiret L et al. Genetic variation at the angiotensinogen locus in relation to high blood pressure and myocardial infarction: the ECTIM Study. J Hypertens 1995; 13: Schunkert H et al. The angiotensinogen T235 variant and the use of antihypertensive drugs in a populationbased cohort. Hypertension 1997; 29: Kunz R et al. Association between the angiotensinogen 235T-variant and essential hypertension in whites: a systematic review and methodological appraisal. Hypertension 1997; 30: Rotimi C et al. Hypertension, serum angiotensinogen, and molecular variants of the angiotensinogen gene among Nigerians. Circulation 1997; 95: Niu T et al. Angiotensinogen gene and hypertension in Chinese. J Clin Invest 1998; 101: Hingorami AD et al. Blood pressure and the M235T polymorphism of the angiotensinogen gene. Hypertension 1996; 28: Brand E et al. Evaluation of the angiotensinogen locus in human essential hypertension: a European study. Hypertension 1998; 31: Tiret L et al. Gene polymorphisms of the renin angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: the PEGASE study. Projet d Etude des Gene de l Hypertension Arterielle Severe a moderee Essentielle. J Hypertens 1998; 16: Vasan RS et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. New Engl J Med 2001; 345: Rankinen T et al. AGT M235T and ACE ID polymorphisms and exercise blood pressure in the HERITAGE Family Study. Am J Physiol Heart Circ Physiol 2000; 279: H368 H

Treatment A Placebo to match COREG CR 20 mg OD + Lisinopril 10 mg OD (Days 1-7) Placebo to match COREG CR 40 mg OD + Lisinopril 10 mg OD (Days 8-14)

Treatment A Placebo to match COREG CR 20 mg OD + Lisinopril 10 mg OD (Days 1-7) Placebo to match COREG CR 40 mg OD + Lisinopril 10 mg OD (Days 8-14) The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

University of Padova, Padua, Italy, and HARVEST Study Group, Italy

University of Padova, Padua, Italy, and HARVEST Study Group, Italy University of Padova, Padua, Italy, and HARVEST Study Group, Italy ISOLATED SYSTOLIC HYPERTENSION IN THE YOUNG DOES NOT IMPLY AN INCREASED RISK OF FUTURE HYPERTENSION NEEDING TREATMENT Mos L, Saladini

More information

PREVALENCE OF HYPERTENSION AND ITS ASSOCIATED RISK FACTORS AMONG SCHOOL AGE CHILDREN

PREVALENCE OF HYPERTENSION AND ITS ASSOCIATED RISK FACTORS AMONG SCHOOL AGE CHILDREN PREVALENCE OF HYPERTENSION AND ITS ASSOCIATED RISK FACTORS AMONG SCHOOL AGE CHILDREN DR.AZAD ABDUL JABAR HALEEM AL-MEZORI- Dohuk Medical school/ University of Duhok-Kurdistan- Iraq Prof. Dr. AbbasAl-Rabaty-HawlerMedical

More information

Association between G-217A polymorphism in the AGT gene and essential hypertension: a meta-analysis

Association between G-217A polymorphism in the AGT gene and essential hypertension: a meta-analysis Association between G-217A polymorphism in the AGT gene and essential hypertension: a meta-analysis R. Yao*, Y.Y. Du*, Y.Z. Zhang, Q.H. Chen, L.S. Zhao and L. Li Department of Cardiology, the First Affiliated

More information

Positive association of CYP11B2 gene polymorphism with genetic predisposition

Positive association of CYP11B2 gene polymorphism with genetic predisposition (2002) 16, 789 793 & 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh ORIGINAL ARTICLE Positive association of CYP11B2 gene polymorphism with genetic predisposition

More information

Clinical Studies 129

Clinical Studies 129 Clinical Studies 129 Syncope in migraine. The population-based CAMERA study Roland D. Thijs, 1* Mark C. Kruit, 2* Mark A. van Buchem, 2 Michel D. Ferrari, 1 Lenore J. Launer, 3,4 and J. Gert van Dijk

More information

Association between the CYP11B2 gene 344T>C polymorphism and coronary artery disease: a meta-analysis

Association between the CYP11B2 gene 344T>C polymorphism and coronary artery disease: a meta-analysis Association between the CYP11B2 gene 344T>C polymorphism and coronary artery disease: a meta-analysis Y. Liu, H.L. Liu, W. Han, S.J. Yu and J. Zhang Department of Cardiology, The General Hospital of the

More information

SYNOPSIS. Publications No publications at the time of writing this report.

SYNOPSIS. Publications No publications at the time of writing this report. Drug product: TOPROL-XL Drug substance(s): Metoprolol succinate Study code: D4020C00033 (307A) Date: 8 February 2006 SYNOPSIS Dose Ranging, Safety and Tolerability of TOPROL-XL (metoprolol succinate) Extended-release

More information

Blood Pressure Measurement in SPRINT

Blood Pressure Measurement in SPRINT Blood Pressure Measurement in SPRINT Karen C. Johnson, MD, MPH, FAHA Vice Chair, SPRINT Steering Committee University of Tennessee Health Science Center, Department of Preventive Medicine For the SPRINT

More information

Low fractional diastolic pressure in the ascending aorta increased the risk of coronary heart disease

Low fractional diastolic pressure in the ascending aorta increased the risk of coronary heart disease (2002) 16, 837 841 & 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh ORIGINAL ARTICLE Low fractional diastolic pressure in the ascending aorta increased the risk

More information

1. Department of Gynecology and Obstetrics, St. Joseph's Hospital Berlin Tempelhof, Germany

1. Department of Gynecology and Obstetrics, St. Joseph's Hospital Berlin Tempelhof, Germany Page 1 of 9 Validation of the TONOPORT VI ambulatory blood pressure monitor, according to the European Society of Hypertension International Protocol revision 2010 Michael Abou-Dakn 1, Cornelius Döhmen

More information

Yuqing Zhang, M.D., FESC Department of Cardiology, Fu Wai Hospital. CAMS & PUMC, Beijing, China

Yuqing Zhang, M.D., FESC Department of Cardiology, Fu Wai Hospital. CAMS & PUMC, Beijing, China What Can We Learn from the Observational Studies and Clinical Trials of Prehypertension? Yuqing Zhang, M.D., FESC Department of Cardiology, Fu Wai Hospital. CAMS & PUMC, Beijing, China At ARIC visit 4

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Wanner C, Inzucchi SE, Lachin JM, et al. Empagliflozin and

More information

Slide notes: This presentation highlights the issues involved in preventing hypertension. Slide notes are included for the majority of slides,

Slide notes: This presentation highlights the issues involved in preventing hypertension. Slide notes are included for the majority of slides, 3/23/2016 1 This presentation highlights the issues involved in preventing hypertension. Slide notes are included for the majority of slides, containing source materials and references. 2 The Framingham,

More information

Validation of the SEJOY BP-1307 upper arm blood pressure monitor for home. blood pressure monitoring according to the European Society of Hypertension

Validation of the SEJOY BP-1307 upper arm blood pressure monitor for home. blood pressure monitoring according to the European Society of Hypertension Validation of the SEJOY BP-1307 upper arm blood pressure monitor for home blood pressure monitoring according to the European Society of Hypertension International Protocol revision 2010 Short title: Validation

More information

Endothelial function is impaired in women who had pre-eclampsia

Endothelial function is impaired in women who had pre-eclampsia Endothelial function is impaired in women who had pre-eclampsia Christian Delles, Catriona E Brown, Joanne Flynn, David M Carty Institute of Cardiovascular and Medical Sciences University of Glasgow United

More information

Clinical Study Synopsis for Public Disclosure

Clinical Study Synopsis for Public Disclosure abcd Clinical Study Synopsis for Public Disclosure This clinical study synopsis is provided in line with s Policy on Transparency and Publication of Clinical Study Data. The synopsis - which is part of

More information

Normal blood pressure values as perceived by normotensive and hypertensive subjects

Normal blood pressure values as perceived by normotensive and hypertensive subjects ORIGINAL ARTICLE Normal blood pressure values as perceived by normotensive and hypertensive subjects (2003) 17, 87 91 & 2003 Nature Publishing Group All rights reserved 0950-9240/03 $25.00 www.nature.com/jhh

More information

High-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension

High-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension (2005) 19, 491 496 & 2005 Nature Publishing Group All rights reserved 0950-9240/05 $30.00 www.nature.com/jhh ORIGINAL ARTICLE High-dose monotherapy vs low-dose combination therapy of calcium channel blockers

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Pedersen SB, Langsted A, Nordestgaard BG. Nonfasting mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis. JAMA Intern Med. Published online November 7, 2016.

More information

JNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults

JNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults JNC 8 2014 Evidence-Based Guidelines for the Management of High Blood Pressure in Adults Table of Contents Why Do We Treat Hypertension? Blood Pressure Treatment Goals Initial Therapy Strength of Recommendation

More information

Individual Study Table Referring to Item of the Submission: Volume: Page:

Individual Study Table Referring to Item of the Submission: Volume: Page: 2.0 Synopsis Name of Company: Abbott Laboratories Name of Study Drug: Meridia Name of Active Ingredient: Sibutramine hydrochloride monohydrate Individual Study Table Referring to Item of the Submission:

More information

Theoretical and practical questions in the evaluation of arterial function Miklós Illyés MD. Ph.D.

Theoretical and practical questions in the evaluation of arterial function Miklós Illyés MD. Ph.D. Theoretical and practical questions in the evaluation of arterial function Miklós Illyés MD. Ph.D. TensioMed Arterial Stiffness Centre, Budapest Heart Institute, Faculty of Medicine, University of Pécs

More information

Estrogens vs Testosterone for cardiovascular health and longevity

Estrogens vs Testosterone for cardiovascular health and longevity Estrogens vs Testosterone for cardiovascular health and longevity Panagiota Pietri, MD, PhD, FESC Director of Hypertension Unit Athens Medical Center Athens, Greece Women vs Men Is there a difference in

More information

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: ARIC Manuscript Proposal # 1475 PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: Hypertension, left ventricular hypertrophy, and risk of incident hospitalized

More information

The effect of a change in ambient temperature on blood pressure in normotensives

The effect of a change in ambient temperature on blood pressure in normotensives (2001) 15, 113 117 2001 Nature Publishing Group All rights reserved 0950-9240/01 $15.00 www.nature.com/jhh ORIGINAL ARTICLE The effect of a change in ambient temperature on blood pressure in normotensives

More information

The Hypertension Clinic is a part of the Internal Medicine

The Hypertension Clinic is a part of the Internal Medicine Original Article Hypertension Registry at the Bangkok Hospital Medical Center: The First 7 Months Experience OBJECTIVE: The Hypertension Registry at the Bangkok Hospital Medical Center was established

More information

Chapter Two Renal function measures in the adolescent NHANES population

Chapter Two Renal function measures in the adolescent NHANES population 0 Chapter Two Renal function measures in the adolescent NHANES population In youth acquire that which may restore the damage of old age; and if you are mindful that old age has wisdom for its food, you

More information

INCREASED PULSE PRESSURE AND SYSTOLIC x HEART RATE DOUBLE PRODUCT AND CARDIOVASCULAR AUTONOMIC NEUROPATHY IN TYPE 2 DIABETIC PATIENTS

INCREASED PULSE PRESSURE AND SYSTOLIC x HEART RATE DOUBLE PRODUCT AND CARDIOVASCULAR AUTONOMIC NEUROPATHY IN TYPE 2 DIABETIC PATIENTS INCREASED PULSE PRESSURE AND SYSTOLIC x HEART RATE DOUBLE PRODUCT AND CARDIOVASCULAR AUTONOMIC NEUROPATHY IN TYPE 2 DIABETIC PATIENTS A.J. Scheen, J.C. Philips, M. Marchand Division of Diabetes, Nutrition

More information

Hypertension Update Warwick Jaffe Interventional Cardiologist Ascot Hospital

Hypertension Update Warwick Jaffe Interventional Cardiologist Ascot Hospital Hypertension Update 2008 Warwick Jaffe Interventional Cardiologist Ascot Hospital Definition of Hypertension Continuous variable At some point the risk becomes high enough to justify treatment Treatment

More information

PFIZER INC. THERAPEUTIC AREA AND FDA APPROVED INDICATIONS: See USPI.

PFIZER INC. THERAPEUTIC AREA AND FDA APPROVED INDICATIONS: See USPI. PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert. For publications based on this study, see associated bibliography.

More information

Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up

Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up... Study Population: 340... Total Population: 500... Time Window of Baseline: 09/01/13 to 12/20/13... Time Window of Follow-up:

More information

Central pressures and prediction of cardiovascular events in erectile dysfunction patients

Central pressures and prediction of cardiovascular events in erectile dysfunction patients Central pressures and prediction of cardiovascular events in erectile dysfunction patients N. Ioakeimidis, K. Rokkas, A. Angelis, Z. Kratiras, M. Abdelrasoul, C. Georgakopoulos, D. Terentes-Printzios,

More information

Original Research Article

Original Research Article A STUDY TO ESTIMATE SUBCLINICAL ATHEROSCLEROSIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS BY MEASURING THE CAROTID INTIMAL MEDIAL THICKNESS Natarajan Kandasamy 1, Rajan Ganesan 2, Thilakavathi Rajendiran

More information

Clinical Significance of Aldosterone Levels and Low Grade Inflammation in Patients with Coronary Vasospasm

Clinical Significance of Aldosterone Levels and Low Grade Inflammation in Patients with Coronary Vasospasm Clinical Significance of Aldosterone Levels and Low Grade Inflammation in Patients with Coronary Vasospasm Department of Cardiology Keiji Inoue Akira Ueoka, Naoki Maruyama, Yoshiaki Shimoda, Eigo Kishita,

More information

CONTENT SUPPLEMENTARY FIGURE E. INSTRUMENTAL VARIABLE ANALYSIS USING DESEASONALISED PLASMA 25-HYDROXYVITAMIN D. 7

CONTENT SUPPLEMENTARY FIGURE E. INSTRUMENTAL VARIABLE ANALYSIS USING DESEASONALISED PLASMA 25-HYDROXYVITAMIN D. 7 CONTENT FIGURES 3 SUPPLEMENTARY FIGURE A. NUMBER OF PARTICIPANTS AND EVENTS IN THE OBSERVATIONAL AND GENETIC ANALYSES. 3 SUPPLEMENTARY FIGURE B. FLOWCHART SHOWING THE SELECTION PROCESS FOR DETERMINING

More information

Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice

Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice (2005) 19, 801 807 & 2005 Nature Publishing Group All rights reserved 0950-9240/05 $30.00 www.nature.com/jhh ORIGINAL ARTICLE Prognostic significance of blood pressure measured in the office, at home and

More information

A fixed-dose combination of bisoprolol and amlodipine in daily practice treatment of hypertension: Results of a noninvestigational

A fixed-dose combination of bisoprolol and amlodipine in daily practice treatment of hypertension: Results of a noninvestigational Hostalek U et al. Medical Research Archives, vol. 5, issue 11, November 2017 issue Page 1 of 11 RESEARCH ARTICLE A fixed-dose combination of bisoprolol and amlodipine in daily practice treatment of hypertension:

More information

Retrospective Cohort Study for the Evaluation of Life- Style Risk Factors in Developing Metabolic Syndrome under the Estimated Abdominal Circumference

Retrospective Cohort Study for the Evaluation of Life- Style Risk Factors in Developing Metabolic Syndrome under the Estimated Abdominal Circumference Original Asian Pacific Journal of Disease Management 2007; 1(2), 55-63 Retrospective Cohort Study for the Evaluation of Life- Style Risk Factors in Developing Metabolic Syndrome under the Estimated Abdominal

More information

Association of Arg16Gly Polymorphism of the Beta-2 Adrenergic receptor with Baroreflex Sensitivity and Indices of Autonomic Cardiovascular Modulation

Association of Arg16Gly Polymorphism of the Beta-2 Adrenergic receptor with Baroreflex Sensitivity and Indices of Autonomic Cardiovascular Modulation Association of Arg16Gly Polymorphism of the Beta-2 Adrenergic receptor with Baroreflex Sensitivity and Indices of Autonomic Cardiovascular Modulation Ochoa JE 1,2, Correa M 1,5, Gallo J 3,5, McEwen J 1,3,

More information

EXPERIMENTAL and MOLECULAR MEDICINE, Vol. 35, No. 6, , December 2003

EXPERIMENTAL and MOLECULAR MEDICINE, Vol. 35, No. 6, , December 2003 EXPERIMENTAL and MOLECULAR MEDICINE, Vol. 35, No. 6, 545-549, December 2003 Angiotensin converting enzyme I/D, angiotensinogen T174M-M235T and angiotensin II type 1 receptor A1166C gene polymorphisms in

More information

Clinical Study Synopsis

Clinical Study Synopsis Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace

More information

Effects of Renin-Angiotensin System blockade on arterial stiffness and function. Gérard M. LONDON Manhès Hospital Paris, France

Effects of Renin-Angiotensin System blockade on arterial stiffness and function. Gérard M. LONDON Manhès Hospital Paris, France Effects of Renin-Angiotensin System blockade on arterial stiffness and function Gérard M. LONDON Manhès Hospital Paris, France Determinants of vascular overload (afterload) on the heart Peripheral Resistance

More information

Dysglycaemia and Hypertension. Dr E M Manuthu Physician Kitale

Dysglycaemia and Hypertension. Dr E M Manuthu Physician Kitale Dysglycaemia and Hypertension Dr E M Manuthu Physician Kitale None Disclosures DM is MI equivalent MR FIT Objective was to assess predictors of CVD mortality among men with and without diabetes and

More information

Prevalence, awareness, treatment and control of hypertension in employees of factories of Northern Greece: the Naoussa study

Prevalence, awareness, treatment and control of hypertension in employees of factories of Northern Greece: the Naoussa study (2004) 18, 623 629 & 2004 Nature Publishing Group All rights reserved 0950-9240/04 $30.00 www.nature.com/jhh ORIGINAL ARTICLE Prevalence, awareness, treatment and control of hypertension in employees of

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle  holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/1887/35456 holds various files of this Leiden University dissertation. Author: Hassan, Suha Mustafa Title: Toward prevention of Hemoglobinopathies in Oman Issue

More information

Value of cardiac rehabilitation Prof. Dr. L Vanhees

Value of cardiac rehabilitation Prof. Dr. L Vanhees Session: At the interface of hypertension and coronary heart disease haemodynamics, heart and hypertension Value of cardiac rehabilitation Prof. Dr. L Vanhees ESC Stockholm August 2010 Introduction There

More information

Using the New Hypertension Guidelines

Using the New Hypertension Guidelines Using the New Hypertension Guidelines Kamal Henderson, MD Department of Cardiology, Preventive Medicine, University of North Carolina School of Medicine Kotchen TA. Historical trends and milestones in

More information

Nephropathy in Type 1 Diabetes: Can One Identity the Patients at Risk?

Nephropathy in Type 1 Diabetes: Can One Identity the Patients at Risk? Nephropathy in Type 1 Diabetes: Can One Identity the Patients at Risk? Pierre Lefèbvre University of Liège, Belgium Cuba, November 2007 Nephropathy in Type 1 Diabetes It has been known for years that the

More information

a Centre d Investigations Préventives et Cliniques, b Hypertension and Received 18 July 2007 Revised 11 February 2008 Accepted 13 February 2008

a Centre d Investigations Préventives et Cliniques, b Hypertension and Received 18 July 2007 Revised 11 February 2008 Accepted 13 February 2008 1072 Original article Cardiovascular risk as defined in the 2003 European blood pressure classification: the assessment of an additional predictive value of pulse pressure on mortality Frédérique Thomas

More information

Stopping oral contraceptives: an effective blood pressure-lowering intervention in women with hypertension

Stopping oral contraceptives: an effective blood pressure-lowering intervention in women with hypertension (2005) 19, 451 455 & 2005 Nature Publishing Group All rights reserved 0950-9240/05 $30.00 www.nature.com/jhh ORIGINAL ARTICLE Stopping oral contraceptives: an effective blood pressure-lowering intervention

More information

Hypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital

Hypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital Hypertension and obesity Dr Wilson Sugut Moi teaching and referral hospital No conflict of interests to declare Obesity Definition: excessive weight that may impair health BMI Categories Underweight BMI

More information

The hypertensive effects of the renin-angiotensin

The hypertensive effects of the renin-angiotensin Comparison of Telmisartan vs. Valsartan in the Treatment of Mild to Moderate Hypertension Using Ambulatory Blood Pressure Monitoring George Bakris, MD A prospective, randomized, open-label, blinded end-point

More information

Verapamil SR and trandolapril combination therapy in hypertension a clinical trial of factorial design

Verapamil SR and trandolapril combination therapy in hypertension a clinical trial of factorial design Br J Clin Pharmacol 1998; 45: 491 495 Verapamil SR and trandolapril combination therapy in hypertension a clinical trial of factorial design Juergen Scholze, 1 Peter Zilles 2 & Daniele Compagnone 2 on

More information

Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan.

Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan. Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan. Manabu Izumi, Kazuo Suzuki, Tetsuya Sakamoto and Masato Hayashi Jichi Medical University

More information

Special Lecture 11/08/2013. Hypertension Dr. HN Mayrovitz

Special Lecture 11/08/2013. Hypertension Dr. HN Mayrovitz Special Lecture 11/08/2013 Hypertension Dr. HN Mayrovitz Arterial Blood Pressure (ABP) Major Factors Summarized Sympathetic Hormones Arteriole MAP ~ Q x TPR + f (V / C) SV x HR Renal SBP Hypertension =

More information

The German National Cohort (GNC)

The German National Cohort (GNC) The German National Cohort (GNC) 19.11.2015 1 Aims of the German National Cohort To address research questions concerning a wide range of possible causes for major chronic diseases Extensive collection

More information

SUPPLEMENTARY DATA. Supplementary Table 1. Baseline Patient Characteristics

SUPPLEMENTARY DATA. Supplementary Table 1. Baseline Patient Characteristics Supplementary Table 1. Baseline Patient Characteristics Normally distributed data are presented as mean (±SD), data that were not of a normal distribution are presented as median (ICR). The baseline characteristics

More information

Depok-Indonesia STEPS Survey 2003

Depok-Indonesia STEPS Survey 2003 The STEPS survey of chronic disease risk factors in Indonesia/Depok was carried out from February 2003 to March 2003. Indonesia/Depok carried out Step 1, Step 2 and Step 3. Socio demographic and behavioural

More information

DETERMINANTS OF DAY-NIGHT DIFFERENCE IN BLOOD PRESSURE IN SUBJECTS OF AFRICAN ANCESTRY

DETERMINANTS OF DAY-NIGHT DIFFERENCE IN BLOOD PRESSURE IN SUBJECTS OF AFRICAN ANCESTRY i DETERMINANTS OF DAY-NIGHT DIFFERENCE IN BLOOD PRESSURE IN SUBJECTS OF AFRICAN ANCESTRY Joseph Muzi Maseko A dissertation submitted to the Faculty of Health Sciences, University of the Witwatersrand,

More information

T. Suithichaiyakul Cardiomed Chula

T. Suithichaiyakul Cardiomed Chula T. Suithichaiyakul Cardiomed Chula The cardiovascular (CV) continuum: role of risk factors Endothelial Dysfunction Atherosclerosis and left ventricular hypertrophy Myocardial infarction & stroke Endothelial

More information

Section 03: Pre Exercise Evaluations and Risk Factor Assessment

Section 03: Pre Exercise Evaluations and Risk Factor Assessment Section 03: Pre Exercise Evaluations and Risk Factor Assessment ACSM Guidelines: Chapter 3 Pre Exercise Evaluations ACSM Manual: Chapter 3 Risk Factor Assessments HPHE 4450 Dr. Cheatham Purpose The extent

More information

Influence of Age, Hypertension or Myocardial Infarction on Cardiovascular Responses to Changes in Body Position

Influence of Age, Hypertension or Myocardial Infarction on Cardiovascular Responses to Changes in Body Position Influence of Age, Hypertension or Myocardial Infarction on Cardiovascular Responses to Changes in Body Position A population-based study in 30-, 50- and 60-year-old men BY ANNA HOFSTEN UPPSALA UNIVERSITY

More information

Prevention of Atrial Fibrillation and Heart Failure in the Hypertensive Patient

Prevention of Atrial Fibrillation and Heart Failure in the Hypertensive Patient Prevention of Atrial Fibrillation and Heart Failure in the Hypertensive Patient The Issue of Primary Prevention of A.Fib. (and Heart Failure) and not the Prevention of Recurrent A.Fib. after Electroconversion

More information

This Protocol is applicable to Class 1, 2, and Class 3 applicants. Resting ECG shall be performed at the following intervals:

This Protocol is applicable to Class 1, 2, and Class 3 applicants. Resting ECG shall be performed at the following intervals: SCHEDULE 34: PROTOCOL ON ELECTROCARDIOGRAMS ( ECG ) 1. Applicability This Protocol is applicable to Class 1, 2, and Class 3 applicants. 2. Resting ECG Resting ECG shall be perfmed at the following intervals:

More information

Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM

Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM Faculty Disclosure I have no financial interest to disclose No off-label use of medications will be discussed FIFTH ANNUAL SYMPOSIUM Recognize changes between

More information

Association between interleukin-17a polymorphism and coronary artery disease susceptibility in the Chinese Han population

Association between interleukin-17a polymorphism and coronary artery disease susceptibility in the Chinese Han population Association between interleukin-17a polymorphism and coronary artery disease susceptibility in the Chinese Han population G.B. Su, X.L. Guo, X.C. Liu, Q.T. Cui and C.Y. Zhou Department of Cardiothoracic

More information

Long-term Blood Pressure Variability throughout Young Adulthood and Cognitive Function in Midlife; CARDIA study

Long-term Blood Pressure Variability throughout Young Adulthood and Cognitive Function in Midlife; CARDIA study The EPI/NPAM Spring 2014 Scientific Sessions, Hilton San Francisco Union Square, San Francisco, CA Northwestern Mar. 18-21, 2014 University Feinberg School of Medicine Long-term Blood Pressure Variability

More information

Blood Pressure Targets in Diabetes

Blood Pressure Targets in Diabetes Stockholm, 29 th August 2010 ESC Meeting Blood Pressure Targets in Diabetes Peter M Nilsson, MD, PhD Department of Clinical Sciences University Hospital, Malmö Sweden Studies on BP in DM2 ADVANCE RCT (Lancet

More information

Vol. 43, No. 1, September 1997 BIOCHEMISTRY ond MOLECULAR BIOLOGY INTERNATIONAL Pages

Vol. 43, No. 1, September 1997 BIOCHEMISTRY ond MOLECULAR BIOLOGY INTERNATIONAL Pages Vol. 43, No. 1, September 1997 BIOCHEMISTRY ond MOLECULAR BIOLOGY INTERNATIONAL Pages 227-231 ANGIOTENSIN II TYPE I RECEPTOR POLYMORPHISM IN AFRICAN AMERICANS LOWER FREQUENCY OF THE C n66 VARIANT Short

More information

Jared Moore, MD, FACP

Jared Moore, MD, FACP Hypertension 101 Jared Moore, MD, FACP Assistant Program Director, Internal Medicine Residency Clinical Assistant Professor of Internal Medicine Division of General Medicine The Ohio State University Wexner

More information

Prevalence, awareness of hypertension in rural areas of Kurnool

Prevalence, awareness of hypertension in rural areas of Kurnool Original article: Prevalence, awareness of hypertension in rural areas of Kurnool Dr. Sudhakar Babu*, Dr.Aruna MS** *Associate Professor, Dept of Community Medicine, Vishwa Bharathi Medical College Kurnool,

More information

Alexandra Meynier Jan de Vries On behalf of Healthgrain Forum, task force Health Benefits

Alexandra Meynier Jan de Vries On behalf of Healthgrain Forum, task force Health Benefits Factors influencing the outcome of human intervention trials A case study using studies examing the effects of whole grain consumption on blood pressure in humans Alexandra Meynier Jan de Vries On behalf

More information

EFFECT OF PLANT SOURCE DIETARY INTAKE ON BLOOD PRESSURE OF ADULTS IN BAYELSA STATE

EFFECT OF PLANT SOURCE DIETARY INTAKE ON BLOOD PRESSURE OF ADULTS IN BAYELSA STATE EFFECT OF PLANT SOURCE DIETARY INTAKE ON BLOOD PRESSURE OF ADULTS IN BAYELSA STATE 1 Dr. Olusegun, A. Kuforiji & 2 John Samuel 1 Department of Agricultural Technology, Federal Polytechnic, Ekowe, Bayelsa

More information

Effects of exercise, diet and their combination on blood pressure

Effects of exercise, diet and their combination on blood pressure (2005) 19, S20 S24 & 2005 Nature Publishing Group All rights reserved 0950-9240/05 $30.00 www.nature.com/jhh ORIGINAL ARTICLE Effects of exercise, diet and their combination on blood pressure Department

More information

CHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION

CHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION CHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION 3.1 BACKGROUND Diabetes mellitus (DM) and impaired glucose tolerance (IGT) have reached epidemic proportions

More information

New Antihypertensive Strategies to Improve Blood Pressure Control

New Antihypertensive Strategies to Improve Blood Pressure Control New Antihypertensive Strategies to Improve Blood Pressure Control Antonio Coca, MD, PhD,, FRCP, FESC Hypertension and Vascular Risk Unit Department of Internal Medicine. Hospital Clínic (IDIBAPS) University

More information

Predicting failure to follow-up screened high blood pressure in Japan: a cohort study

Predicting failure to follow-up screened high blood pressure in Japan: a cohort study Journal of Public Health Vol. 37, No. 3, pp. 498 505 doi:10.1093/pubmed/fdu056 Advance Access Publication August 7, 2014 Predicting failure to follow-up screened high blood pressure in Japan: a cohort

More information

Tracking of blood pressure in children and adolescents in Germany in the context of risk factors for hypertension

Tracking of blood pressure in children and adolescents in Germany in the context of risk factors for hypertension Tracking of blood pressure in children and adolescents in Germany in the context of risk factors for hypertension G. Sarganas, A. Schaffrath Rosario, C. Albrecht, A. Woll, H. Neuhauser Study population

More information

Metabolic Syndrome and Workplace Outcome

Metabolic Syndrome and Workplace Outcome Metabolic Syndrome and Workplace Outcome Maine Worksite Wellness Initiative June 15, 2010 Alyssa B. Schultz Dee W. Edington Current Definition* of Metabolic Syndrome At least 3 of the following: Waist

More information

Talking about blood pressure

Talking about blood pressure Talking about blood pressure Mrs Khan 56 BP 158/99 BMI 32 Total cholesterol 5.4 (HDL 0.8) HbA1c 43 She has been promising to do more exercise and eat more healthily for the last 2 years but her weight

More information

Biostats Final Project Fall 2002 Dr. Chang Claire Pothier, Michael O'Connor, Carrie Longano, Jodi Zimmerman - CSU

Biostats Final Project Fall 2002 Dr. Chang Claire Pothier, Michael O'Connor, Carrie Longano, Jodi Zimmerman - CSU Biostats Final Project Fall 2002 Dr. Chang Claire Pothier, Michael O'Connor, Carrie Longano, Jodi Zimmerman - CSU Prevalence and Probability of Diabetes in Patients Referred for Stress Testing in Northeast

More information

Hypertension Compendium

Hypertension Compendium Hypertension Compendium Circulation Research Compendium on Hypertension The Epidemiology of Blood Pressure and Its Worldwide Management Genetic and Molecular Aspects of Hypertension Hypertension: Renin

More information

CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES

CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES C. Liakos, 1 G. Vyssoulis, 1 E. Karpanou, 2 S-M. Kyvelou, 1 V. Tzamou, 1 A. Michaelides, 1 A. Triantafyllou, 1 P. Spanos, 1 C. Stefanadis

More information

Current status on other health effects:

Current status on other health effects: Current status on other health effects: Changes in Cardiovascular Risk Factors after the Great East Japan Earthquake Tetsuya Ohira, MD, PhD. Department of Epidemiology, Fukushima Medical University School

More information

DISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE

DISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE DISCLOSURES Editor-in-Chief- Nephrology- UpToDate- (Wolters Klewer) Richard J. Glassock, MD, MACP Geffen School of Medicine at UCLA 1 st Annual Internal

More information

Genetic bottlenecks, perceived racism, and hypertension risk among African Americans and first-generation African immigrants

Genetic bottlenecks, perceived racism, and hypertension risk among African Americans and first-generation African immigrants (2001) 15, 341 351 2001 Nature Publishing Group All rights reserved 0950-9240/01 $15.00 www.nature.com/jhh ORIGINAL ARTICLE Genetic bottlenecks, perceived racism, and hypertension risk among African Americans

More information

ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults

ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults ORIGINAL INVESTIGATION C-Reactive Protein Concentration and Incident Hypertension in Young Adults The CARDIA Study Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; Stephen

More information

Supplement materials:

Supplement materials: Supplement materials: Table S1: ICD-9 codes used to define prevalent comorbid conditions and incident conditions Comorbid condition ICD-9 code Hypertension 401-405 Diabetes mellitus 250.x Myocardial infarction

More information

Implications of Drug-related Increases in Blood Pressure

Implications of Drug-related Increases in Blood Pressure Implications of Drug-related Increases in Blood Pressure Preston M. Dunnmon, MD, FACP, FACC Division of Cardiovascular and Renal Products US Food and Drug Administration July 18, 2012 Disclaimer The findings

More information

Managing hypertension: a question of STRATHE

Managing hypertension: a question of STRATHE (2005) 19, S3 S7 & 2005 Nature Publishing Group All rights reserved 0950-9240/05 $30.00 www.nature.com/jhh ORIGINAL ARTICLE Managing hypertension: a question of STRATHE Department of Cardiovascular Disease,

More information

Val-MARC: Valsartan-Managing Blood Pressure Aggressively and Evaluating Reductions in hs-crp

Val-MARC: Valsartan-Managing Blood Pressure Aggressively and Evaluating Reductions in hs-crp Página 1 de 5 Return to Medscape coverage of: American Society of Hypertension 21st Annual Scientific Meeting and Exposition Val-MARC: Valsartan-Managing Blood Pressure Aggressively and Evaluating Reductions

More information

Clinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8. Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital

Clinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8. Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital Clinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8 Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital Objectives Review the Eighth Joint National Committee (JNC

More information

Hypertension JNC 8 (2014)

Hypertension JNC 8 (2014) Hypertension JNC 8 (2014) Renewed: February 2018 Updated: February 2015 Comparison of Seventh Joint National Committee (JNC 7) vs. Eighth Joint National Committee (JNC 8) Hypertension Guidelines Methodology

More information

Population: All participants Number of Obs: Variable # Sas Name: Sas Label: Categories: Variable # Sas Name: F80VNUM. Sas Label: Categories:

Population: All participants Number of Obs: Variable # Sas Name: Sas Label: Categories: Variable # Sas Name: F80VNUM. Sas Label: Categories: Form - Last Update: 04/6/001 umber of Obs: 161771 Participant ID 1 ID Participant ID F Days since randomization/enrollment 161771-886 8-59451 516548 FDAYS F Days since randomization/enrollment F Visit

More information

Riboflavin to lower blood pressure, a targeted nutrition approach

Riboflavin to lower blood pressure, a targeted nutrition approach Riboflavin to lower blood pressure, a targeted nutrition approach Mary Ward RD, PhD Northern Ireland Centre for Food & Health (NICHE) / The Nutrition Society (UK) ulster.ac.uk Outline Background: Hypertension

More information

Treating Heart Failure in Biodiverse Patient Populations: Best Practices and Unveiling Disparities in Blacks

Treating Heart Failure in Biodiverse Patient Populations: Best Practices and Unveiling Disparities in Blacks Treating Heart Failure in Biodiverse Patient Populations: Best Practices and Unveiling Disparities in Blacks 12th Annual Leadership Summit on Health Disparities & Congressional Black Caucus Spring Health

More information

Know Your Number Aggregate Report Single Analysis Compared to National Averages

Know Your Number Aggregate Report Single Analysis Compared to National Averages Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Xu X, Qin X, Li Y, et al. Efficacy of folic acid therapy on the progression of chronic kidney disease: the Renal Substudy of the China Stroke Primary Prevention Trial. JAMA

More information